Skip to content

Notes Issued1 at other companies

Repligen logo
RepligenRGEN
$0
Grow Generation logo
Grow GenerationGRWG
$0
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$0
Asure Software logo
Asure SoftwareASUR
$879K-23.6%
ATI
Archimedes Tech SPAC Partners II Co. Ordinary SharesATII
$0-100%
ORI
Origin Investment Corp I Ordinary SharesORIQ
$0-100%

Other financials

Income statement

See full
Revenue$61.9M+2.5%
Gross profit$22.8M+9.5%
Operating income-$6.1M+10.3%
Net income-$3.3M+37.2%
EPS (diluted)-$0.09+35.7%

Balance sheet

See full
Cash & equivalents$29.8M-27.8%
Total debt$2.7M-50.2%
Total equity$193.7M-15.5%
Total assets$243.3M-16.9%

Cash flow

See full
Operating cash flow-$4.1M-99.4%
CapEx$1.6M+31.9%
Free cash flow-$5.7M-74.9%

Valuation

See full
Market cap$121.48M-10.5%
Enterprise value$94.38M-16.4%
P/S0.5×-0.1×

Profitability

See full
Gross margin33.7%-1.0pp
Operating margin-23.4%-3.1pp
Net margin-17.7%-5.3pp
FCF margin-5.6%-26.8pp

Returns & leverage

See full
Return on equity-21.1%-4.7pp
Debt / equity0.0×
Current ratio4.4×-0.1×

Where this comes from

Reported directly by Clarus Corporation in its filing.

Tagged under the XBRL concept us-gaap:NotesIssued1.

The official record: Clarus Corporation’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clarus Corporation's notes issued1.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarus Corporation's notes issued1?
Clarus Corporation (CLAR) reported notes issued1 of $469.5K in Q4 2024.
What does notes issued1 mean?
This represents the cash proceeds received from the issuance of debt securities or promissory notes to investors or lenders. It reflects the company's ability to raise capital through debt markets to support growth initiatives or manage capital structure. Analysts monitor this to evaluate the company's debt-raising capacity and cost of capital.